RWD195 Persistence Rates of Second-Line Biologics in Psoriasis Following First-Line Biologic Treatment Based on Nationwide Data From Greece

Autor:	Ravanidis, S. 1, Stefanou, G. 1, Tsolakidis, A. 2, Mathioudakis, K. 2, Lazaridou, E. 3, Apalla, Z. 3, Kourlaba, G. 4
Zdroj:	In Value in Health December 2024 27(12) Supplement:S612-S612
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect